期刊文献+

过氧化物酶增殖子活化受体-γsiRNA腺病毒载体的构建 被引量:1

Construction of pAdeno-siPPARγ
下载PDF
导出
摘要 目的:构建针对过氧化物酶体增殖子活化受体-γ(PPARγ)基因的siRNA腺病毒载体。方法:依据siR-NA设计原则,在PPARγmRNA(AF013266)序列中设计2个特异性靶序列(36-54、73-91),体外合成对应发卡样DNAs,退火后先将其克隆入pSIREN-Shuttle载体,再亚克隆入pAdeno腺病毒载体,对插入序列进行DNA序列分析。结果:发卡样siRNA单链DNA寡核苷酸退火后,电泳可见明亮靶条带。连接退火寡核苷酸和pSIREN-Shuttle载体得到阳性克隆pSIREN-Shuttle-siPPARγ-36、pSIREN-Shuttle-siPPARγ-73。同源重组后得到亚克隆pAdeno-siPPARγ-36、pAdeno-siPPARγ-73,测序证实插入序列与设计序列完全一致。结论:成功构建2个靶向PPARγ基因的siRNA载体pAdeno-siPPARγ-36和pAdeno-siPPARγ-73。 Aim: To construct the siRNA adenovirus vector targeting peroxisome proliferator-activated receptor-γ (PPARγ). Methods:Two specificity target sequences( 36-54.73-91 from PPARγ mRNA sequencer AF013266 were designed according to the principle of design on siRNA, then the corresponding hairpin-shaped DNA fragment was synthesized in vitro. The product was cloned into pSIREN-Shuttle vector after annealing,then subeloned into siRNA adenovirus vector pAdeno. The insertion DNA sequences were analyzed. Results : The hairpin-shaped siRNA single strand DNA oligonucleotide showed an obvious electrophoresis strip after annealing. The positive clones pSIREN-Shuttle-siPPARγ-36 and pSIREN-Shuttle-siPPARγ-73 were obtained by connecting the annealed oligonucleotide with pSIREN-Shuttle vector. Positive subclone pAdeno-siPPARγ-36 and pAdeno-siPPARγ-73 were obtained by homologous recombination. The inserted sequences were confirmed by sequencing. Conclusion: Two siRNA adenovirus vector targeting PPARγ,pAdeno-siPPARγ-36 and pAdeno-siPPARγ-73, are successfully constructed.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第3期477-479,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目30672128
关键词 RNA干扰 过氧化物酶体增殖子活化受体-γ 腺病毒载体 克隆 RNA interference PPARγ adenovirus vector clone
  • 相关文献

参考文献7

二级参考文献11

共引文献28

同被引文献13

  • 1王朝霞,王科明,韩亮,陆彬彬,束永前.重组人p53腺病毒注射液联合泰索帝对人肺腺癌细胞生长的抑制作用[J].实用临床医药杂志,2006,10(6):13-17. 被引量:2
  • 2Ashhab Y, Alian A, Polliack A, et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern[J].FEBS Lett, 2001,495 ( 1 - 2) : 56 - 60.
  • 3Crnkovis-Mertens I, Hoppe-Seyter F, Butz K. Induction of apoptosis in tumor ceils by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene[J]. Oncogene, 2003, 22(51): 8330-8336.
  • 4Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2^△△CT method [ J ]. Methods, 2001, 25(4) : 402 -408.
  • 5Augello C, Caruso L, Marco M, et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma[J]. BMC cancer, 2009, 9: 125.
  • 6Liu H, Kong C, Zeng Y, et al. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment[J]. Urologic Oncology, 2009, 27(3) : 277 -283.
  • 7Kempkensteffen C, Hinz S, Krause H, et al. Expression of splicing variants of the inhibitor of apoptosis Livin in testicular germ cell tumors [J].Tumor Biology, 2008, 29(2): 76- 82.
  • 8Zhang Q P, Xiong J, Jin Y X, et al. CC ehemokine ligand 25 enhances resistance to apoptosis in CD^4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation[J]. Cancer Res, 2004, 64(20): 7579-7587.
  • 9Hayashi S, Leu D, Yamii Y, et al. Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation [ J ]. Transplantation, 2005, 80(4) : 494 - 499.
  • 10Kanerva A, Hemminki A. Adenoviruses for treatment of cancer[ J]. Ann Med, 2005, 37(1) : 33 -43.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部